The Ramco Cements (RAMCOCEM) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
22 May, 2026Executive summary
Audited standalone and consolidated financial results for the quarter and year ended 31 March 2026 were approved, with a recommended dividend of Rs.2.50 per share for FY26.
The business operates as a single segment: cement and cement-related products.
Financial highlights
Standalone revenue for FY26 was Rs.9,055.92 crore, up from Rs.8,539.10 crore year-over-year; consolidated revenue was Rs.9,070.22 crore, up from Rs.8,559.57 crore.
Standalone net profit after tax for FY26 was Rs.693.62 crore, up from Rs.417.39 crore; consolidated net profit attributable to equity holders was Rs.698.65 crore, up from Rs.272.65 crore.
Standalone EPS for FY26 was Rs.29.33, up from Rs.17.65; consolidated EPS was Rs.29.56, up from Rs.11.53.
Exceptional items for FY26 included Rs.573.52 crore profit on sale of surplus lands and a non-recurring Rs.20.35 crore charge due to new labour codes.
Outlook and guidance
The Board recommended a dividend of Rs.2.50 per share for FY26, subject to approval at the AGM.
Latest events from The Ramco Cements
- Net profit surged in Q3 FY26 on higher revenue and exceptional gains, with robust financial ratios.RAMCOCEM
Q3 25/269 Feb 2026 - Profitability fell on weak prices, but expansion, sustainability, and legal risks persist.RAMCOCEM
Q1 24/2524 Nov 2025 - Q2 FY26 saw higher revenue, profit, and margins, with a key subsidiary merger approved.RAMCOCEM
Q2 25/265 Nov 2025 - Q2 FY25 saw steep declines in revenue and profit, but expansion and regulatory challenges persist.RAMCOCEM
Q2 24/254 Sep 2025 - Net profit jumped on asset sales, but revenue fell and regulatory risks remain.RAMCOCEM
Q3 24/254 Sep 2025 - Standalone profit rose but consolidated profit and margins declined; new Tamil Nadu tax to raise costs.RAMCOCEM
Q4 24/254 Sep 2025 - Net profit surged in Q1 FY26, with Ramco Windfarms Limited becoming a wholly owned subsidiary.RAMCOCEM
Q1 25/264 Sep 2025